Both slow gut transit and cut food volume, which can lower daily mineral intake
While they share similar goals and benefits, they are not identical drugs, and their differences can matter when it comes to effectiveness, side effects, and overall suitability for an individual patient
Originally developed for type 2 diabetes management, Semaglutide has garnered significant interest for its weight loss effects
It helps with general tracking, not diagnosis, eligibility, or treatment decisions
Terapia de combinacin con otros medicamentos para el tratamiento de la diabetes
While no serious safety signals unique to retatrutide have been identified in Phase 2 data, the glucagon receptor agonism component raises theoretical considerations around hepatic glucose output and potential effects on heart rate, which are being monitored closely in ongoing Phase 3 trials